| Mild elevation of urinary biomarkers in prerenal acute kidney injury K Doi, D Katagiri, K Negishi, S Hasegawa, Y Hamasaki, T Fujita, ... Kidney international 82 (10), 1114-1120, 2012 | 101 | 2012 |
| The oral hypoxia-inducible factor prolyl hydroxylase inhibitor enarodustat counteracts alterations in renal energy metabolism in the early stages of diabetic kidney disease S Hasegawa, T Tanaka, T Saito, K Fukui, T Wakashima, EA Susaki, ... Kidney international 97 (5), 934-950, 2020 | 97 | 2020 |
| Hypoxia-inducible factor stabilizers for treating anemia of chronic kidney disease S Hasegawa, T Tanaka, M Nangaku Current Opinion in Nephrology and Hypertension 27 (5), 331-338, 2018 | 61 | 2018 |
| Dietary metabolites and chronic kidney disease S Hasegawa, TM Jao, R Inagi Nutrients 9 (4), 358, 2017 | 47 | 2017 |
| Lysophosphatidylcholine mediates fast decline in kidney function in diabetic kidney disease K Yoshioka, Y Hirakawa, M Kurano, Y Ube, Y Ono, K Kojima, T Iwama, ... Kidney International 101 (3), 510-526, 2022 | 45 | 2022 |
| Comprehensive three-dimensional analysis (CUBIC-kidney) visualizes abnormal renal sympathetic nerves after ischemia/reperfusion injury S Hasegawa, EA Susaki, T Tanaka, H Komaba, T Wada, M Fukagawa, ... Kidney international 96 (1), 129-138, 2019 | 42 | 2019 |
| Activation of sympathetic signaling in macrophages blocks systemic inflammation and protects against renal ischemia-reperfusion injury S Hasegawa, T Inoue, Y Nakamura, D Fukaya, R Uni, CH Wu, R Fujii, ... Journal of the American Society of Nephrology 32 (7), 1599-1615, 2021 | 22 | 2021 |
| Vagus nerve stimulation even after injury ameliorates cisplatin-induced nephropathy via reducing macrophage infiltration R Uni, T Inoue, Y Nakamura, D Fukaya, S Hasegawa, CH Wu, R Fujii, ... Scientific Reports 10 (1), 9472, 2020 | 18 | 2020 |
| Organelle stress and crosstalk in kidney disease S Hasegawa, R Inagi Kidney360 1 (10), 1157-1164, 2020 | 17 | 2020 |
| IgG4-related disease combined with autoimmune hemolytic anemia and steroid-responsive transient hypercalcemia S Hasegawa, S Mine, S Hagiwara Clinical Medicine Insights: Case Reports 8, CCRep. S25553, 2015 | 16 | 2015 |
| Harnessing metabolomics to describe the pathophysiology underlying progression in diabetic kidney disease S Hasegawa, R Inagi Current Diabetes Reports 21 (7), 21, 2021 | 13 | 2021 |
| Decreased IFT88 expression with primary cilia shortening causes mitochondrial dysfunction in cisplatin-induced tubular injury R Fujii, S Hasegawa, H Maekawa, T Inoue, K Yoshioka, R Uni, Y Ikeda, ... American Journal of Physiology-Renal Physiology 321 (3), F278-F292, 2021 | 12 | 2021 |
| Neuroimmune interactions and kidney disease S Hasegawa, T Inoue, R Inagi Kidney Research and Clinical Practice 38 (3), 282, 2019 | 11 | 2019 |
| Association between diabetes and major bleeding complications of renal biopsy S Hasegawa, A Okada, S Aso, R Kumazawa, H Matsui, K Fushimi, ... Kidney International Reports 7 (2), 232-240, 2022 | 10 | 2022 |
| Non-uniform progression of chronic tubulointerstitial nephritis and widespread nephrocalcification in a patient with anorexia nervosa S Hasegawa, M Shibata, M Mochizuki, T Katsuki, M Tada, F Hinoshita Internal Medicine 56 (5), 545-549, 2017 | 6 | 2017 |
| Bone marrow stromal cell antigen-1 (CD157) regulated by sphingosine kinase 2 mediates kidney fibrosis T Inoue, Y Nakamura, S Tanaka, T Kohro, LX Li, L Huang, J Yao, ... Frontiers in Medicine 9, 993698, 2022 | 5 | 2022 |
| Recent advances in renal regeneration S Hasegawa, T Tanaka, M Nangaku F1000Research 8, 2019 | 5 | 2019 |
| Whole-Body and Whole-Organ 3D Imaging of Hypoxia Using an Activatable Covalent Fluorescent Probe Compatible with Tissue Clearing DM Sakamoto, I Tamura, B Yi, S Hasegawa, Y Saito, N Yamada, ... ACS nano 18 (6), 5167-5179, 2024 | 3 | 2024 |
| Activation of α7 nicotinic acetylcholine receptors attenuates monocyte–endothelial adhesion through FUT7 inhibition CH Wu, T Inoue, Y Nakamura, R Uni, S Hasegawa, H Maekawa, ... Biochemical and Biophysical Research Communications 590, 89-96, 2022 | 3 | 2022 |
| SGLT2 inhibition in chronic kidney disease: a preventive strategy against acute kidney injury at the same time? S Hasegawa, M Nangaku Kidney International 101 (1), 20-22, 2022 | 2 | 2022 |
Masaomi NangakuDivision of Nephrology and Endocrinology, the University of Tokyo Graduate School of Medicine在 umin.ac.jp 的电子邮件经过验证
